Raffles Medical - RHB Invest 2023-09-28: Will Continue To Operate Changi TCF; BUY

• Raffles Medical has been awarded the contract to continue providing medical services at Connect@Changi as a transitional care facility (TCF) or COVID-19 treatment facility (CTF) until Feb 2025.
• - Read this at SGinvestors.io -
• Raffles Medical’s 1-year forward P/E and FY24E implied P/E based on our target price remains well below the regional peer average.

TCF contact extension.

• According to the GeBIZ website, on 20 Sep, Raffles Medical (SGX:BSL) was awarded the contract for the provision of medical services at Connect@Changi as a TCF or CTF at Hall 9, and at Hall 10 as a CTF. There were nine bidders for the open tender, and Raffles Medical had the lowest bid value of S$151,392.
• - Read this at SGinvestors.io -
• We note that each bidder had placed a bid for different levels of MOQ.

Revenue potential.

• Read more at SGinvestors.io.

Above is an excerpt from a report by RHB Securities Research.
Clients of RHB may be the first to access the full PDF report @ https://www.rhbtradesmart.com/.

Read also RHB's most recent report:
2025-02-25 Raffles Medical Group - Expecting Steady Improvements.

Previous report by RHB:
2024-07-30 Raffles Medical - 1H24 Numbers Below Expectations.

Price targets by 4 other brokers at Raffles Medical Target Prices.

Listing of research reports at Raffles Medical Analyst Reports.

Relevant links:
Raffles Medical Share Price History,
Raffles Medical Announcements,
Raffles Medical Dividend Payout Dates & Corporate Actions,
Raffles Medical News